Mycophenolate Mofetil
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
De Novo Renal Transplant Recipient.
Conditions
De Novo Renal Transplant Recipient.
Trial Timeline
May 1, 2003 → Apr 1, 2006
NCT ID
NCT00166244About Mycophenolate Mofetil
Mycophenolate Mofetil is a approved stage product being developed by Roche for De Novo Renal Transplant Recipient.. The current trial status is completed. This product is registered under clinical trial identifier NCT00166244. Target conditions include De Novo Renal Transplant Recipient..
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (8)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01213394 | Phase 3 | Terminated |
| NCT01014442 | Phase 3 | Completed |
| NCT00333437 | Pre-clinical | Completed |
| NCT00187941 | Phase 1 | Completed |
| NCT00788567 | Phase 3 | Completed |
| NCT00166244 | Approved | Completed |
| NCT00199667 | Approved | UNKNOWN |
| NCT00193635 | Phase 1 | Completed |
Competing Products
19 competing products in De Novo Renal Transplant Recipient.